Scleroderma fibroblasts show increased responsiveness to endothelial cell-derived IL-1 and bFGF

Journal of Investigative Dermatology

Volumn 108, Issue 3, 1997, Pages 269-274

  Denton, Christopher P ^a,b   Shi wen, Xu ^b   Black, Carol M ^b   Pearson, Jeremy D ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

endothelium; fibrosis; leucine; thymidine

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1;

ARTICLE; CELL CULTURE; COCULTURE; CONTROLLED STUDY; CULTURE MEDIUM; DNA SYNTHESIS; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SCLERODERMA; SKIN FIBROBLAST;

EID: 0031044637     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/1523-1747.ep12286455     Document Type: Article

References (48)

1. Abraham D, Lupoli S, McWhirter A, Plater-Zyberk C, Piela TH, Korn JH, Olsen I, Black CM: Expression and function of surface antigens on scleroderma fibroblasts. Arthritis Rheum 34:1164-1172, 1991
2. Antonelli-Orlidge A, Saunders KB, Smith SR, O'Amore PA: An activated form of TGF-β is produced by co-cultures of endothelial cells and pericytes. Proc Natl Acad Sci USA 86:4544-4548, 1989
3. Bashey RI, Jimenez SA: Increased sensitivity of scleroderma fibroblasts in culture to stimulation of protein and collagen synthesis by serum. Biochem Biophys Res Commun 76:1214-1222, 1977
4. Black CM: The aetiopathogenesis of systemic sclerosis. J Intern Med 234:3-8, 1993
5. Black CM: Measurement of skin involvement in scleroderma. J Rheumatol 22:1217-1219, 1995
6. Buckingham RB, Prince RK, Rodnan G: Progressive systemic sclerosis dermal fibroblasts symhesise increased amounts of glycosaminoglycans. J Lab Clin Med 101:659-669, 1983
7. Carvalho D, Savage COS, Black CM, Pearson JD: IgG antiendothelial antibodies from scleroderma patients induce leucocyte adhesion to human vascular endothelial cells in vitro. J Clin Invest 97:111-119, 1996
8. Cho MM, Jimenez SA, Johnson BA, Harlow LA, Burrows JC, Koch AE: In vitro cytokine modulation of intercellular adhesion molecule-1 expression on systemic sclerosis dermal fibroblasts. Pathobiology 62:73-81, 1994
9. Clozel M, Breu V, Gray G, Kalina B, Loffler BM, Burri K, Cassal JM, Hirth G, Muller M, Neidhart W: Pharmacological characterisation of bosentan a new potent oraly active non-peptide endothelin receptor antagonist. J Pharmacol Exp Ther 270: 228-235, 1994
10. Dejana E, Mantovani A: II.-1 stimulates II.-6 production in endotlielial cells. J Immunol 142:549-553, 1989
11. Denton CP, Shiwen X, Welsh KI, Pearson JD, Black CM: Scleroderma fibroblast phenotype is modulated by co-culture with human endothelial cells. J Rheumatol 23:633-638, 1996
12. Dicorleto PE, Bowen-Pope DF: Cultured endotlielial cells produce a platelet derived growth factor like protein. Proc Natl Acad Sci USA 80:1919-1923, 1983
13. Eguchi K, Migita K, Nakashima M, Ida H, Terada K, Sakai M, Kasvakami A, Aoyagi T, Ishimaru T, Nagataki S: Fibroblast growth factors released from wounded endotlielial cells stimulate proliferation of synovial cells. J Rheumatol 19:1925-1932, 1992
14. Fickling SA, Tooze JA, and Whitley G St J: Characterisation of human umbilical vein endothelial cell lines produced by produced by transfection with the early region of SV40. Exp Cell Res 201:517-521, 1992
15. Fleischmajor R, Perlish JS, Kreig T, Timpl R: Variability in collagen and fibronectin synthesis by scleroderma fibroblasts in primary culture. J Invest Drrmatol 76:400-403, 1981
16. Guarda E, Myers PR, Brilla CG, Tyagi SC, Weber KT: Endothelial cell induced modulation of cardiac fibroblast collagen metabolism. Cardiovasc Res 27:1004-1008, 1993
17. Igarashi A, Nashiro K, Kikuchi K, Sato S, Ihn H, Fujimoto M, Crotendorst GR, Takehara K: Connective tissue growth factor gene expression from localised scleroderma, and other fibrotic skin disorders. J Invest Dermatol 106:729-733, 1996
18. Igarashi A, Nashiro K, Kikuchi K, Sato S, Ihn H, Grotendorst GR, Takehara K: Significant correlation between connective tissue growth factor gene expression and skin sclerosis in tissue sections from patients with systemic sclerosis. J Invest Dermatol 105:280-284, 1995
19. Ivarsson M, McWhirter A, Black CM, Rubin K: Impaired regulation of collagen pro-α1(1) mRNA and change in pattern of collagen binding integrins on scleroderma fibroblasts. J Invest Dermatol 101:216-221, 1993
20. Jaffe EA Nachman RL, Becker CG, Minick CR: Culture of human endothelial cells derived from human umbilical veins. J Clin Invest 52:2745-2756, 1973
21. Kahaleh MB: Endothelin, an endothelial-dependent vasoconstrictor in scleroderma. Arthritis Rheum 34:978-983, 1991
22. Kahaleh MB: Vascular Disease in Scleroderma: Endothelial T lymphocyte-fibroblast interactions. Rheum Dis Clin North Am 16:57-73, 1990
23. Kawaguchi Y: IL-1α gene expression and protein production by fibroblasts from patients with systemic sclerosis. Clin Exp Immunol 97:445-450, 1994
24. Kawaguchi Y, Harigai M, Suzuki K, Hara M, Kobayashi K, Ishizuka T, Matsuki Y, Tanaka N, Nakamura M: Interleukin 1 receptors on fibroblasts from systemic sclerosis patients induce excessive functional responses to IL-1β. Biochem Biophys Res Commun 190:154-161, 1993
25. Kikuchi K, Yamakage A, Smith E, LeRoy E, Trjanowska M: Differential modulation of bFGF receptors by TGF-β in adult skin, scleroderma skill and newborn foreskin fibroblasts. J Invest Dermatol 99:201-205, 1992
26. Koch AE, Kronfield-Harrington LB, Szechnecz Z, Cho MM, Haines GK, Harlow LA, Streiter RM, Kunkel SL, Massa MC, Barr WG, Jimenez SA: In situ expression of cytokines and cellular adhesion molecules in the skin of patients with systemic sclerosis. Pathobiology 61:239-246, 1993
27. Kraling BM, Jimenez SA, Sorger T, Maul CG: Isolation and characterisation of microvascular endothelial cells from the adult human dermis and from skin biopsies of patients with systemic sclerosis Lab Invest 71:745-54, 1994
28. LeRoy EC: Increased collagen synthesis by scleroderma skin fibroblasts in vitro. A possible defect in regulation or activation of scleroderma fibroblasts. J Clin Invest 54:880-889, 1974
29. LeRoy EC: The control nf fibrosis in systemic sclerosis: a strategy involving extracellular matrix, cytokines, and growth factors. J Dermatol 21:1-4, 1994
30. LeRoy EC, Mercurio SM, Sherer GK: Replication and phenotypic expression of control and scleroderma human fibroblasts: responses to growth factors. Proc Natl Acad Sci USA 79:1286-1290, 1982
31. Mauch C, Eckes B, Hunzelman N, Oono T, Kozlowska E, Krieg T: Control of fibrosis in systemic scleroderma. J Invest Dermatol 100:92S-96S, 1993
32. Mauch C, Kozlowska E, Eckes B, Krieg T: Altered regulation of collagen metabolism in scleroderma fibroblasts grown within 3-dimensional collagen gels. Exp Dermatol 1:185-190, 1992
33. McNeil PL, Muthukrishnan L, Warder E, DAmore PA: Growth factors are released by mechanically wounded endothelial cells. J Cell Biol 109:811-822, 1989
34. Mignatti P, Rifkin: Release ot basic fibroblast growth factor, an angiogenic factor devoid of secretory signal sequence: a trivial phenomenon or a novel secretion mechanism?. J Cell Biochem 47:201-207, 1991
35. Mosmann T: Rapid colorimetric assay for cellular growth and survival. Application to proliferation and cytotoxicity assays. J Immunol Methods 65:55-63, 1983
36. Pearson JD: The endothelium: its role in systemic sclerosis. Ann Rheum Dis 50:866-871, 1992
37. Pober JS, Bevilacqua MP, Mendrick DL, Lapierre LA, Fiers W, Gimbrone MA: Two distinct monokines, IL-1 and TNF each independently induce biosynthesis and transient expression of the same antigen on the surface of cultured human vascular endothelial cells. J Immunol 136:1680-1687, 1986
38. Prescott RJ, Freemont AJ, Jones CJ, Hoyland J, Fielding P: Sequential dermal microvascular and perivascular changes in the development of scleroderma. J Pathol 166:255-263, 1992
39. Schartfetter K, Lankat-Buttgereit B, Kreig T: Localisation of collagen mRNA in normal and scleroderma skin by in situ hybridization. Eur J Clin Invest 18:9-17, 1988
40. Schweigerer L, Neufeld G, Friedman J, Abraham JA, Fiddes JC, Gospodarowicz D: Capillary endothelial cells express basic fibroblast growth factor, a mitogen that promotes their own growth. Nature 325:257-259, 1987
41. Shi-wen X, Panesar M, Vancheeswaran R, Mason J, Haskard DO, Black CM, Olsen I, Abraham D: Expression and shedding of ICAM-1 and LFA-3 by normal and scleroderma fibroblasts. Arthritis Rheum 37:89-97, 1994
42. Smith TH, Korn JH: Lymphocyte modulation of fibroblast function in systemic sclerosis. Clin Dermatol 12:369-377, 1994
43. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee: Preliminary Criteria for the Classification of Systemic Sclerosis (Scleroderma). Arthritis Rheum 23:581-590, 1980
44. Swerlick RA, Lawley TJ: The Role of microvascular endothelial cells in inflammation: J Invest Dermatol 100(suppl):111S-115S, 1993
45. Takehara K, Soma Y, Igarashi A, Kikuchi K, Moro A, Ishibashi Y: Response of scleroderma fibroblasts to various growth factors. Arch Dermatol Res 283:461-464, 1991
46. Villanueva AG, Farber HW, Rounds S, Goldstein RH: Stimulation of fibroblast collagen and total protein formation by an endothelial-cell derived factor. Circ Res 69:134-141, 1991
47. Wagner OF, Christ G, Wojta J, Vierhapper H, Parzer S, Nowotny PJ, Schneider B, Waldhausl W, Binder BR: Polar secretion of ET-1 by cultured endothelial cells. J Biol Chem 267:16066-16068, 1992
48. Yamakage A, Kikuchi K, Smith E, LeRoy EC, Trojanowska M: Selective up-regulation of PDGF-α receptors by TGF-β in scleroderma fibroblasts. J Exp Med 175:1227-1234, 1992